These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33803276)

  • 1. Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma.
    Banella S; Quarta E; Colombo P; Sonvico F; Pagnoni A; Bortolotti F; Colombo G
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33803276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Assessment of Cisplatin/Hyaluronan Complex for Loco-Regional Chemotherapy.
    Banella S; Saraswat A; Patel A; Serajuddin ATM; Colombo P; Patel K; Colombo G
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model.
    Sonvico F; Barbieri S; Colombo P; Barocelli E; Mucchino C; Cantoni AM; Petronini PG; Rusca M; Carbognani P; Ampollini L
    Eur J Pharm Sci; 2018 Oct; 123():89-97. PubMed ID: 30030099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model.
    Ampollini L; Barocelli E; Cavazzoni A; Petronini P; Mucchino C; Cantoni AM; Leonardi F; Ventura L; Barbieri S; Colombo P; Fusari A; Carbognani P; Rusca M; Sonvico F
    J Thorac Dis; 2018 Jan; 10(Suppl 2):S207-S220. PubMed ID: 29507788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma.
    Sonvico F; Barbieri S; Colombo P; Mucchino C; Barocelli E; Cantoni AM; Cavazzoni A; Petronini PG; Rusca M; Carbognani P; Ampollini L
    J Thorac Dis; 2018 Jan; 10(Suppl 2):S194-S206. PubMed ID: 29507787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
    Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
    Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
    Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
    Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
    Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines.
    Rimoldi I; Coccè V; Facchetti G; Alessandri G; Brini AT; Sisto F; Parati E; Cavicchini L; Lucchini G; Petrella F; Ciusani E; Pessina A
    Biomed Pharmacother; 2018 Dec; 108():111-118. PubMed ID: 30218855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional pharmacokinetic selectivity of intrapleural cisplatin.
    Bogliolo GV; Lerza R; Bottino GB; Mencoboni MP; Pannacciulli IM; Vannozzi M; Fulco RA; Merlo F; Esposito M
    Eur J Cancer; 1991; 27(7):839-42. PubMed ID: 1834113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma.
    Markman M; Cleary S; Pfeifle C; Howell SB
    Cancer; 1986 Jul; 58(1):18-21. PubMed ID: 3708543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
    Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
    Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion.
    Lerza R; Vannozzi MO; Tolino G; Viale M; Bottino GB; Bogliolo G; Cerruti A; Castello G; Mencoboni M; Reggiardo G; Pannacciulli I; Esposito M
    Ann Oncol; 1997 Apr; 8(4):385-91. PubMed ID: 9209670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.
    Ratto GB; Civalleri D; Esposito M; Spessa E; Alloisio A; De Cian F; Vannozzi MO
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):759-65. PubMed ID: 10096972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative therapies: intraoperative intracavitary chemotherapy.
    Chang MY; Sugarbaker DJ
    Thorac Surg Clin; 2004 Nov; 14(4):549-56. PubMed ID: 15559062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
    Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P
    Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
    Richards WG; Zellos L; Bueno R; Jaklitsch MT; Jänne PA; Chirieac LR; Yeap BY; Dekkers RJ; Hartigan PM; Capalbo L; Sugarbaker DJ
    J Clin Oncol; 2006 Apr; 24(10):1561-7. PubMed ID: 16575008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.